Global Complement Protein C5 Inhibitors Market Growth 2026-2032

January 2026 | 94 pages | ID: GC6EBA3E6CE1EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Complement Protein C5 Inhibitors market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Complement protein C5 inhibitors are drugs that block the activity of complement protein C5, a key component of the immune system's complement pathway. By inhibiting C5, these drugs prevent the formation of C5a and C5b. This reduces immune-mediated damage in diseases like paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and neuromyelitis optica spectrum disorder (NMOSD).

United States market for Complement Protein C5 Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Complement Protein C5 Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Complement Protein C5 Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Complement Protein C5 Inhibitors players cover UCB, Regeneron Pharmaceuticals, Astellas Pharma, Alexion Pharmaceuticals, Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Complement Protein C5 Inhibitors Industry Forecast? looks at past sales and reviews total world Complement Protein C5 Inhibitors sales in 2025, providing a comprehensive analysis by region and market sector of projected Complement Protein C5 Inhibitors sales for 2026 through 2032. With Complement Protein C5 Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Complement Protein C5 Inhibitors industry.

This Insight Report provides a comprehensive analysis of the global Complement Protein C5 Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Complement Protein C5 Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Complement Protein C5 Inhibitors market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Complement Protein C5 Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Complement Protein C5 Inhibitors.

This report presents a comprehensive overview, market shares, and growth opportunities of Complement Protein C5 Inhibitors market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Oral Administration
  • Intravenous Injection
  • Subcutaneous Administration
Segmentation by Application:
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Atypical Hemolytic Uremic Syndrome (aHUS)
  • Neuromyelitis Optica Spectrum Disorde (NMOSD)
  • Geographic Atrophy (GA)
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • UCB
  • Regeneron Pharmaceuticals
  • Astellas Pharma
  • Alexion Pharmaceuticals
  • Roche
  • Amgen
  • Samsung Bioepis
Key Questions Addressed in this Report
What is the 10-year outlook for the global Complement Protein C5 Inhibitors market?
What factors are driving Complement Protein C5 Inhibitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Complement Protein C5 Inhibitors market opportunities vary by end market size?
How does Complement Protein C5 Inhibitors break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Complement Protein C5 Inhibitors Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Complement Protein C5 Inhibitors by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Complement Protein C5 Inhibitors by Country/Region, 2021, 2025 & 2032
2.2 Complement Protein C5 Inhibitors Segment by Type
  2.2.1 Oral Administration
  2.2.2 Intravenous Injection
  2.2.3 Subcutaneous Administration
  2.2.4 Complement Protein C5 Inhibitors Sales by Type
    2.2.4.1 Global Complement Protein C5 Inhibitors Sales Market Share by Type (2021-2026)
    2.2.4.2 Global Complement Protein C5 Inhibitors Revenue and Market Share by Type (2021-2026)
    2.2.4.3 Global Complement Protein C5 Inhibitors Sale Price by Type (2021-2026)
2.3 Complement Protein C5 Inhibitors Segment by Application
  2.3.1 Paroxysmal Nocturnal Hemoglobinuria (PNH)
  2.3.2 Atypical Hemolytic Uremic Syndrome (aHUS)
  2.3.3 Neuromyelitis Optica Spectrum Disorde (NMOSD)
  2.3.4 Geographic Atrophy (GA)
  2.3.5 Others
  2.3.6 Complement Protein C5 Inhibitors Sales by Application
    2.3.6.1 Global Complement Protein C5 Inhibitors Sale Market Share by Application (2021-2026)
    2.3.6.2 Global Complement Protein C5 Inhibitors Revenue and Market Share by Application (2021-2026)
    2.3.6.3 Global Complement Protein C5 Inhibitors Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Complement Protein C5 Inhibitors Breakdown Data by Company
  3.1.1 Global Complement Protein C5 Inhibitors Annual Sales by Company (2021-2026)
  3.1.2 Global Complement Protein C5 Inhibitors Sales Market Share by Company (2021-2026)
3.2 Global Complement Protein C5 Inhibitors Annual Revenue by Company (2021-2026)
  3.2.1 Global Complement Protein C5 Inhibitors Revenue by Company (2021-2026)
  3.2.2 Global Complement Protein C5 Inhibitors Revenue Market Share by Company (2021-2026)
3.3 Global Complement Protein C5 Inhibitors Sale Price by Company
3.4 Key Manufacturers Complement Protein C5 Inhibitors Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Complement Protein C5 Inhibitors Product Location Distribution
  3.4.2 Players Complement Protein C5 Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR COMPLEMENT PROTEIN C5 INHIBITORS BY GEOGRAPHIC REGION

4.1 World Historic Complement Protein C5 Inhibitors Market Size by Geographic Region (2021-2026)
  4.1.1 Global Complement Protein C5 Inhibitors Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Complement Protein C5 Inhibitors Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Complement Protein C5 Inhibitors Market Size by Country/Region (2021-2026)
  4.2.1 Global Complement Protein C5 Inhibitors Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Complement Protein C5 Inhibitors Annual Revenue by Country/Region (2021-2026)
4.3 Americas Complement Protein C5 Inhibitors Sales Growth
4.4 APAC Complement Protein C5 Inhibitors Sales Growth
4.5 Europe Complement Protein C5 Inhibitors Sales Growth
4.6 Middle East & Africa Complement Protein C5 Inhibitors Sales Growth

5 AMERICAS

5.1 Americas Complement Protein C5 Inhibitors Sales by Country
  5.1.1 Americas Complement Protein C5 Inhibitors Sales by Country (2021-2026)
  5.1.2 Americas Complement Protein C5 Inhibitors Revenue by Country (2021-2026)
5.2 Americas Complement Protein C5 Inhibitors Sales by Type (2021-2026)
5.3 Americas Complement Protein C5 Inhibitors Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Complement Protein C5 Inhibitors Sales by Region
  6.1.1 APAC Complement Protein C5 Inhibitors Sales by Region (2021-2026)
  6.1.2 APAC Complement Protein C5 Inhibitors Revenue by Region (2021-2026)
6.2 APAC Complement Protein C5 Inhibitors Sales by Type (2021-2026)
6.3 APAC Complement Protein C5 Inhibitors Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Complement Protein C5 Inhibitors by Country
  7.1.1 Europe Complement Protein C5 Inhibitors Sales by Country (2021-2026)
  7.1.2 Europe Complement Protein C5 Inhibitors Revenue by Country (2021-2026)
7.2 Europe Complement Protein C5 Inhibitors Sales by Type (2021-2026)
7.3 Europe Complement Protein C5 Inhibitors Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Complement Protein C5 Inhibitors by Country
  8.1.1 Middle East & Africa Complement Protein C5 Inhibitors Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Complement Protein C5 Inhibitors Revenue by Country (2021-2026)
8.2 Middle East & Africa Complement Protein C5 Inhibitors Sales by Type (2021-2026)
8.3 Middle East & Africa Complement Protein C5 Inhibitors Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Complement Protein C5 Inhibitors
10.3 Manufacturing Process Analysis of Complement Protein C5 Inhibitors
10.4 Industry Chain Structure of Complement Protein C5 Inhibitors

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Complement Protein C5 Inhibitors Distributors
11.3 Complement Protein C5 Inhibitors Customer

12 WORLD FORECAST REVIEW FOR COMPLEMENT PROTEIN C5 INHIBITORS BY GEOGRAPHIC REGION

12.1 Global Complement Protein C5 Inhibitors Market Size Forecast by Region
  12.1.1 Global Complement Protein C5 Inhibitors Forecast by Region (2027-2032)
  12.1.2 Global Complement Protein C5 Inhibitors Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Complement Protein C5 Inhibitors Forecast by Type (2027-2032)
12.7 Global Complement Protein C5 Inhibitors Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 UCB
  13.1.1 UCB Company Information
  13.1.2 UCB Complement Protein C5 Inhibitors Product Portfolios and Specifications
  13.1.3 UCB Complement Protein C5 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 UCB Main Business Overview
  13.1.5 UCB Latest Developments
13.2 Regeneron Pharmaceuticals
  13.2.1 Regeneron Pharmaceuticals Company Information
  13.2.2 Regeneron Pharmaceuticals Complement Protein C5 Inhibitors Product Portfolios and Specifications
  13.2.3 Regeneron Pharmaceuticals Complement Protein C5 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Regeneron Pharmaceuticals Main Business Overview
  13.2.5 Regeneron Pharmaceuticals Latest Developments
13.3 Astellas Pharma
  13.3.1 Astellas Pharma Company Information
  13.3.2 Astellas Pharma Complement Protein C5 Inhibitors Product Portfolios and Specifications
  13.3.3 Astellas Pharma Complement Protein C5 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Astellas Pharma Main Business Overview
  13.3.5 Astellas Pharma Latest Developments
13.4 Alexion Pharmaceuticals
  13.4.1 Alexion Pharmaceuticals Company Information
  13.4.2 Alexion Pharmaceuticals Complement Protein C5 Inhibitors Product Portfolios and Specifications
  13.4.3 Alexion Pharmaceuticals Complement Protein C5 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Alexion Pharmaceuticals Main Business Overview
  13.4.5 Alexion Pharmaceuticals Latest Developments
13.5 Roche
  13.5.1 Roche Company Information
  13.5.2 Roche Complement Protein C5 Inhibitors Product Portfolios and Specifications
  13.5.3 Roche Complement Protein C5 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Roche Main Business Overview
  13.5.5 Roche Latest Developments
13.6 Amgen
  13.6.1 Amgen Company Information
  13.6.2 Amgen Complement Protein C5 Inhibitors Product Portfolios and Specifications
  13.6.3 Amgen Complement Protein C5 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Amgen Main Business Overview
  13.6.5 Amgen Latest Developments
13.7 Samsung Bioepis
  13.7.1 Samsung Bioepis Company Information
  13.7.2 Samsung Bioepis Complement Protein C5 Inhibitors Product Portfolios and Specifications
  13.7.3 Samsung Bioepis Complement Protein C5 Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Samsung Bioepis Main Business Overview
  13.7.5 Samsung Bioepis Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Complement Protein C5 Inhibitors Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Complement Protein C5 Inhibitors Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral Administration
Table 4. Major Players of Intravenous Injection
Table 5. Major Players of Subcutaneous Administration
Table 6. Global Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 7. Global Complement Protein C5 Inhibitors Sales Market Share by Type (2021-2026)
Table 8. Global Complement Protein C5 Inhibitors Revenue by Type (2021-2026) & ($ million)
Table 9. Global Complement Protein C5 Inhibitors Revenue Market Share by Type (2021-2026)
Table 10. Global Complement Protein C5 Inhibitors Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Complement Protein C5 Inhibitors Sale by Application (2021-2026) & (K Units)
Table 12. Global Complement Protein C5 Inhibitors Sale Market Share by Application (2021-2026)
Table 13. Global Complement Protein C5 Inhibitors Revenue by Application (2021-2026) & ($ million)
Table 14. Global Complement Protein C5 Inhibitors Revenue Market Share by Application (2021-2026)
Table 15. Global Complement Protein C5 Inhibitors Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Complement Protein C5 Inhibitors Sales by Company (2021-2026) & (K Units)
Table 17. Global Complement Protein C5 Inhibitors Sales Market Share by Company (2021-2026)
Table 18. Global Complement Protein C5 Inhibitors Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Complement Protein C5 Inhibitors Revenue Market Share by Company (2021-2026)
Table 20. Global Complement Protein C5 Inhibitors Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Complement Protein C5 Inhibitors Producing Area Distribution and Sales Area
Table 22. Players Complement Protein C5 Inhibitors Products Offered
Table 23. Complement Protein C5 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Complement Protein C5 Inhibitors Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Complement Protein C5 Inhibitors Sales Market Share Geographic Region (2021-2026)
Table 28. Global Complement Protein C5 Inhibitors Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Complement Protein C5 Inhibitors Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Complement Protein C5 Inhibitors Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Complement Protein C5 Inhibitors Sales Market Share by Country/Region (2021-2026)
Table 32. Global Complement Protein C5 Inhibitors Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Complement Protein C5 Inhibitors Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Complement Protein C5 Inhibitors Sales by Country (2021-2026) & (K Units)
Table 35. Americas Complement Protein C5 Inhibitors Sales Market Share by Country (2021-2026)
Table 36. Americas Complement Protein C5 Inhibitors Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 38. Americas Complement Protein C5 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 39. APAC Complement Protein C5 Inhibitors Sales by Region (2021-2026) & (K Units)
Table 40. APAC Complement Protein C5 Inhibitors Sales Market Share by Region (2021-2026)
Table 41. APAC Complement Protein C5 Inhibitors Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 43. APAC Complement Protein C5 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 44. Europe Complement Protein C5 Inhibitors Sales by Country (2021-2026) & (K Units)
Table 45. Europe Complement Protein C5 Inhibitors Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 47. Europe Complement Protein C5 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Complement Protein C5 Inhibitors Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Complement Protein C5 Inhibitors Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Complement Protein C5 Inhibitors Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Complement Protein C5 Inhibitors
Table 53. Key Market Challenges & Risks of Complement Protein C5 Inhibitors
Table 54. Key Industry Trends of Complement Protein C5 Inhibitors
Table 55. Complement Protein C5 Inhibitors Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Complement Protein C5 Inhibitors Distributors List
Table 58. Complement Protein C5 Inhibitors Customer List
Table 59. Global Complement Protein C5 Inhibitors Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Complement Protein C5 Inhibitors Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Complement Protein C5 Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Complement Protein C5 Inhibitors Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Complement Protein C5 Inhibitors Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Complement Protein C5 Inhibitors Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Complement Protein C5 Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Complement Protein C5 Inhibitors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Complement Protein C5 Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Complement Protein C5 Inhibitors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Complement Protein C5 Inhibitors Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Complement Protein C5 Inhibitors Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Complement Protein C5 Inhibitors Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Complement Protein C5 Inhibitors Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. UCB Basic Information, Complement Protein C5 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 74. UCB Complement Protein C5 Inhibitors Product Portfolios and Specifications
Table 75. UCB Complement Protein C5 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. UCB Main Business
Table 77. UCB Latest Developments
Table 78. Regeneron Pharmaceuticals Basic Information, Complement Protein C5 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 79. Regeneron Pharmaceuticals Complement Protein C5 Inhibitors Product Portfolios and Specifications
Table 80. Regeneron Pharmaceuticals Complement Protein C5 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Regeneron Pharmaceuticals Main Business
Table 82. Regeneron Pharmaceuticals Latest Developments
Table 83. Astellas Pharma Basic Information, Complement Protein C5 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 84. Astellas Pharma Complement Protein C5 Inhibitors Product Portfolios and Specifications
Table 85. Astellas Pharma Complement Protein C5 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Astellas Pharma Main Business
Table 87. Astellas Pharma Latest Developments
Table 88. Alexion Pharmaceuticals Basic Information, Complement Protein C5 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 89. Alexion Pharmaceuticals Complement Protein C5 Inhibitors Product Portfolios and Specifications
Table 90. Alexion Pharmaceuticals Complement Protein C5 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Alexion Pharmaceuticals Main Business
Table 92. Alexion Pharmaceuticals Latest Developments
Table 93. Roche Basic Information, Complement Protein C5 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 94. Roche Complement Protein C5 Inhibitors Product Portfolios and Specifications
Table 95. Roche Complement Protein C5 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Roche Main Business
Table 97. Roche Latest Developments
Table 98. Amgen Basic Information, Complement Protein C5 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 99. Amgen Complement Protein C5 Inhibitors Product Portfolios and Specifications
Table 100. Amgen Complement Protein C5 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Amgen Main Business
Table 102. Amgen Latest Developments
Table 103. Samsung Bioepis Basic Information, Complement Protein C5 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 104. Samsung Bioepis Complement Protein C5 Inhibitors Product Portfolios and Specifications
Table 105. Samsung Bioepis Complement Protein C5 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Samsung Bioepis Main Business
Table 107. Samsung Bioepis Latest Developments

LIST OF FIGURES

Figure 1. Picture of Complement Protein C5 Inhibitors
Figure 2. Complement Protein C5 Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Complement Protein C5 Inhibitors Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Complement Protein C5 Inhibitors Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Complement Protein C5 Inhibitors Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Complement Protein C5 Inhibitors Sales Market Share by Country/Region (2025)
Figure 10. Complement Protein C5 Inhibitors Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral Administration
Figure 12. Product Picture of Intravenous Injection
Figure 13. Product Picture of Subcutaneous Administration
Figure 14. Global Complement Protein C5 Inhibitors Sales Market Share by Type in 2026
Figure 15. Global Complement Protein C5 Inhibitors Revenue Market Share by Type (2021-2026)
Figure 16. Complement Protein C5 Inhibitors Consumed in Paroxysmal Nocturnal Hemoglobinuria (PNH)
Figure 17. Global Complement Protein C5 Inhibitors Market: Paroxysmal Nocturnal Hemoglobinuria (PNH) (2021-2026) & (K Units)
Figure 18. Complement Protein C5 Inhibitors Consumed in Atypical Hemolytic Uremic Syndrome (aHUS)
Figure 19. Global Complement Protein C5 Inhibitors Market: Atypical Hemolytic Uremic Syndrome (aHUS) (2021-2026) & (K Units)
Figure 20. Complement Protein C5 Inhibitors Consumed in Neuromyelitis Optica Spectrum Disorde (NMOSD)
Figure 21. Global Complement Protein C5 Inhibitors Market: Neuromyelitis Optica Spectrum Disorde (NMOSD) (2021-2026) & (K Units)
Figure 22. Complement Protein C5 Inhibitors Consumed in Geographic Atrophy (GA)
Figure 23. Global Complement Protein C5 Inhibitors Market: Geographic Atrophy (GA) (2021-2026) & (K Units)
Figure 24. Complement Protein C5 Inhibitors Consumed in Others
Figure 25. Global Complement Protein C5 Inhibitors Market: Others (2021-2026) & (K Units)
Figure 26. Global Complement Protein C5 Inhibitors Sale Market Share by Application (2025)
Figure 27. Global Complement Protein C5 Inhibitors Revenue Market Share by Application in 2026
Figure 28. Complement Protein C5 Inhibitors Sales by Company in 2026 (K Units)
Figure 29. Global Complement Protein C5 Inhibitors Sales Market Share by Company in 2026
Figure 30. Complement Protein C5 Inhibitors Revenue by Company in 2026 ($ millions)
Figure 31. Global Complement Protein C5 Inhibitors Revenue Market Share by Company in 2026
Figure 32. Global Complement Protein C5 Inhibitors Sales Market Share by Geographic Region (2021-2026)
Figure 33. Global Complement Protein C5 Inhibitors Revenue Market Share by Geographic Region in 2026
Figure 34. Americas Complement Protein C5 Inhibitors Sales 2021-2026 (K Units)
Figure 35. Americas Complement Protein C5 Inhibitors Revenue 2021-2026 ($ millions)
Figure 36. APAC Complement Protein C5 Inhibitors Sales 2021-2026 (K Units)
Figure 37. APAC Complement Protein C5 Inhibitors Revenue 2021-2026 ($ millions)
Figure 38. Europe Complement Protein C5 Inhibitors Sales 2021-2026 (K Units)
Figure 39. Europe Complement Protein C5 Inhibitors Revenue 2021-2026 ($ millions)
Figure 40. Middle East & Africa Complement Protein C5 Inhibitors Sales 2021-2026 (K Units)
Figure 41. Middle East & Africa Complement Protein C5 Inhibitors Revenue 2021-2026 ($ millions)
Figure 42. Americas Complement Protein C5 Inhibitors Sales Market Share by Country in 2026
Figure 43. Americas Complement Protein C5 Inhibitors Revenue Market Share by Country (2021-2026)
Figure 44. Americas Complement Protein C5 Inhibitors Sales Market Share by Type (2021-2026)
Figure 45. Americas Complement Protein C5 Inhibitors Sales Market Share by Application (2021-2026)
Figure 46. United States Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 47. Canada Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 48. Mexico Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 49. Brazil Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 50. APAC Complement Protein C5 Inhibitors Sales Market Share by Region in 2026
Figure 51. APAC Complement Protein C5 Inhibitors Revenue Market Share by Region (2021-2026)
Figure 52. APAC Complement Protein C5 Inhibitors Sales Market Share by Type (2021-2026)
Figure 53. APAC Complement Protein C5 Inhibitors Sales Market Share by Application (2021-2026)
Figure 54. China Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 55. Japan Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 56. South Korea Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 57. Southeast Asia Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 58. India Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 59. Australia Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 60. China Taiwan Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 61. Europe Complement Protein C5 Inhibitors Sales Market Share by Country in 2026
Figure 62. Europe Complement Protein C5 Inhibitors Revenue Market Share by Country (2021-2026)
Figure 63. Europe Complement Protein C5 Inhibitors Sales Market Share by Type (2021-2026)
Figure 64. Europe Complement Protein C5 Inhibitors Sales Market Share by Application (2021-2026)
Figure 65. Germany Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 66. France Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 67. UK Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 68. Italy Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 69. Russia Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 70. Middle East & Africa Complement Protein C5 Inhibitors Sales Market Share by Country (2021-2026)
Figure 71. Middle East & Africa Complement Protein C5 Inhibitors Sales Market Share by Type (2021-2026)
Figure 72. Middle East & Africa Complement Protein C5 Inhibitors Sales Market Share by Application (2021-2026)
Figure 73. Egypt Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 74. South Africa Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 75. Israel Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 76. Turkey Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 77. GCC Countries Complement Protein C5 Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Complement Protein C5 Inhibitors in 2026
Figure 79. Manufacturing Process Analysis of Complement Protein C5 Inhibitors
Figure 80. Industry Chain Structure of Complement Protein C5 Inhibitors
Figure 81. Channels of Distribution
Figure 82. Global Complement Protein C5 Inhibitors Sales Market Forecast by Region (2027-2032)
Figure 83. Global Complement Protein C5 Inhibitors Revenue Market Share Forecast by Region (2027-2032)
Figure 84. Global Complement Protein C5 Inhibitors Sales Market Share Forecast by Type (2027-2032)
Figure 85. Global Complement Protein C5 Inhibitors Revenue Market Share Forecast by Type (2027-2032)
Figure 86. Global Complement Protein C5 Inhibitors Sales Market Share Forecast by Application (2027-2032)
Figure 87. Global Complement Protein C5 Inhibitors Revenue Market Share Forecast by Application (2027-2032)